PT Merck Tbk (IDX:MERK)
4,000.00
+10.00 (0.25%)
Aug 12, 2026, 3:34 PM WIB
PT Merck Tbk Revenue
PT Merck Tbk had revenue of 347.13B IDR in the quarter ending June 30, 2026, with 31.00% growth. This brings the company's revenue in the last twelve months to 1.35T, up 29.17% year-over-year. In the year 2025, PT Merck Tbk had annual revenue of 1.20T with 15.81% growth.
Revenue (ttm)
1.35T
Revenue Growth
+29.17%
P/S Ratio
1.33
Revenue / Employee
3.77B
Employees
358
Market Cap
1.79T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.20T | 163.92B | 15.81% |
| Dec 31, 2024 | 1.04T | 75.31B | 7.83% |
| Dec 31, 2023 | 961.43B | -163.17B | -14.51% |
| Dec 31, 2022 | 1.12T | 60.20B | 5.66% |
| Dec 31, 2021 | 1.06T | 408.55B | 62.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 37.72T |
| PT Medela Potentia Tbk | 15.64T |
| PT Siloam International Hospitals Tbk | 13.51T |
| PT Kimia Farma Tbk | 9.56T |
| PT Mitra Keluarga Karyasehat Tbk | 5.57T |
| PT Pyridam Farma Tbk | 2.99T |
| PT Sejahteraraya Anugrahjaya Tbk | 2.70T |
| PT Prodia Widyahusada Tbk | 2.37T |